NLRP3 and colitis: Taken together, these results indicated that ROS-induced mitochondrial damage might be a dominant mechanism of underlying activation of the NLRP3 inflammasome in colitis by treatment with Schisandrin B through AMPK/Nrf2 signaling pathway.